Beyond Achondroplasia

Growing together with Clara

March 28, 2016
by inesp.alves
1 Comment

Patent and license agreement for CNP

Article credits: “the pharma letter” Chugai and BioMarin ink exclusive sublicense agreement   Japanese drug major Chugai Pharmaceutical (TYO: 4519) has concluded an exclusive sublicense agreement with US rare disease drug developer BioMarin Pharmaceutical (Nasdaq: BMRN) on the patent of Chugai’s … Continue reading

Translate »